Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
Clinical trial NCT00002451 · UNKNOWN
Trial details
- NCT number
- NCT00002451
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.